Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current challenges in cystic fibrosis screening.

Elaine Lyon1, Christine Miller

  • 1ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, Utah 84108, USA. lyone@aruplab.com

Archives of Pathology & Laboratory Medicine
|August 30, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analysis Of Salivary Herpesviruses Reveals Associations Between HHV-6 And Long COVID Severity.

medRxiv : the preprint server for health sciences·2026
Same author

Generation of an induced pluripotent stem cell line, JHUi006-A, from a Marfan Syndrome patient harboring a pathogenic c.5225-2A > C intronic splicing variant.

Stem cell research·2026
Same author

Perceived motivators and barriers to research engagement for psychologists in an Australian public healthcare service: insights from the research capacity and culture survey.

Australian health review : a publication of the Australian Hospital Association·2025
Same author

An Infectious Disease Mimicking Rheumatologic Disease in an Adolescent.

Clinical pediatrics·2025
Same author

Optimization of Current Procedural Terminology Coding in Complex Genitourinary Surgical Specimens.

Archives of pathology & laboratory medicine·2025
Same author

Pan-lysyl oxidase inhibition disrupts fibroinflammatory tumor stroma, rendering cholangiocarcinoma susceptible to chemotherapy.

Hepatology communications·2024

Cystic Fibrosis (CF) testing guidelines and methods are reviewed, highlighting differences in classic and atypical CF presentations. Accurate patient data is crucial for effective CF screening and reproductive options.

Area of Science:

  • Medical Genetics
  • Molecular Diagnostics

Background:

  • Overview of classic and atypical cystic fibrosis (CF) symptoms and mutations.
  • Discussion of current CF mutation detection testing methods.

Purpose of the Study:

  • Review CF testing guidelines from ACMG and ACOG for population screening.
  • Describe symptomatic and mutational differences in classic vs. atypical CF.
  • Address challenges in CF testing, including genotype-phenotype correlation and preanalytic/analytic/postanalytic phases.

Main Methods:

  • Review of current CF transmembrane conductance regulator (CFTR) gene mutation detection methods.
  • Analysis of advantages and disadvantages of each detection method.
  • Identification of essential patient information (ethnicity, family history, test purpose) for risk assessment.

Related Experiment Videos

Main Results:

  • Commercially available reagents meet technical challenges for detecting recommended CFTR mutations.
  • Persistent challenges exist in the preanalytic and postanalytic phases of CF testing.
  • Accurate patient information is vital for laboratories to provide meaningful risk reduction based on negative genetic test results.

Conclusions:

  • Improved healthcare provider knowledge of CF testing recommendations enhances screening efficiency and accuracy.
  • Increased assay sensitivity in laboratories benefits patients through prompt treatment.
  • Enhanced CF screening provides expanded reproductive options for carriers.